Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tuesday, 24 March 2026 10:00 AM Innit Spins Off New B2C AI Health Venture - Kind Intelligence Foundry - Launching GLP-1 Companion "Glo" Tuesday, 24 March 2026 10:00 AM Company Update Kind Intelligence Foundry's first product, Glo, is an SMS-based AI companion for people on GLP-1 medications such as Ozempic, Wegovy, Zepbound, and Mounjaro, now available in alpha at askglo.ai SAN FRANCISCO, CA / ACCESS Newswire / March 24, 2026 / Today, Innit announced the spin-off Kind Intelligence Foundry (K.I
PMID 2004615 Stanley TL, et al
It's important to monitor your caffeine intake and adjust it according to your personal tolerance levels to enjoy the benefits of Yerba Mate without experiencing any adverse effects
Typically, payers have justified covering GLP-1 therapies by targeting co-morbidities rather than obesity alone
Contact us for more information
US$ 22.43
US$ 26.64
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
US$ 23.54
US$ 23.26
US$ 25.27
US$ 26.64
